FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/11/096862 [Registered on: 03/11/2025] Trial Registered Prospectively
Last Modified On: 03/11/2025
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   Cross Sectional Study 
Study Design  Other 
Public Title of Study   Quality of life among women with cancer cervix receiving brachytherapy as a part of treatment in a selected cancer care centre in North east India. 
Scientific Title of Study   A study to assess the quality of life (QOL) among women with cervical cancer receiving brachytherapy as a part of definitive radiation treatment in a selected cancer care centre, North east India. 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Yanpothung Yanthan 
Designation  Assistant Professor 
Affiliation  Dr. Bhubaneswar Borooah cancer Institute 
Address  AK Azad Road, Gopinath Nagar Rd, Bishnu Rabha Nagar, Guwahati

Kamrup
ASSAM
781016
India 
Phone  9612551001  
Fax    
Email  yanyanthan@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Yanpothung Yanthan 
Designation  Assistant Professor 
Affiliation  Dr. Bhubaneswar Borooah cancer Institute 
Address  AK Azad Road, Gopinath Nagar Rd, Bishnu Rabha Nagar, Guwahati

Kamrup
ASSAM
781016
India 
Phone  9612551001  
Fax    
Email  yanyanthan@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Yanpothung Yanthan 
Designation  Assistant Professor 
Affiliation  Dr. Bhubaneswar Borooah cancer Institute 
Address  AK Azad Road, Gopinath Nagar Rd, Bishnu Rabha Nagar, Guwahati

Kamrup
ASSAM
781016
India 
Phone  9612551001  
Fax    
Email  yanyanthan@gmail.com  
 
Source of Monetary or Material Support  
Dr. B. Borooah cancer Institute, Gopinath Nagar, A. K. Azad Road, Guwahati, Kamrup, Assam, 781016 
 
Primary Sponsor  
Name  Dr. B Borooah Cancer Institute 
Address  A. K. Azad Road, Gopinath Nagar, Guwahati 781016 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Yorum yama  Dr. B Borooah Cancer Institute  A. K. Azad Road, Gopinath Nagar Guwahati, 781016
Kamrup
ASSAM 
9362730314

yorumyama@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Medical ethics committee, BBCI  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: C539||Malignant neoplasm of cervix uteri, unspecified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Nil  Nil 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  80.00 Year(s)
Gender  Female 
Details  Patient diagnosed with cervical cancer and undergoing brachytherapy as a part definitive radiation therapy
Patients on follow-up who had completed brachytherapy within the last 3 months.
Adults aged 18 years and above, regardless of menopausal status.
Patients who are willing to participate in the study.
Patients who can understand English, Hindi or Assamese.
 
 
ExclusionCriteria 
Details  Patients with severe co-morbidities such as advanced cardiovascular disease, uncontrolled diabetes, or chronic kidney/liver failure that could independently affect quality of life (QoL) and functionality. 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
To determine the quality of life among women with cervical cancer receiving brachytherapy as a part of definitive radiation treatment.   At 4 weeks of conclusion of brachytherapy 
 
Secondary Outcome  
Outcome  TimePoints 
To find the correlation between the quality of life & the selected demographic variables  At 8 weeks of conclusion of the sample collections  
 
Target Sample Size   Total Sample Size="40"
Sample Size from India="40" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   15/11/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="1"
Days="14" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This is prospective observational cross-sectional trial to assess the quality of life in patients of carcinoma cervix receiving brachytherapy as part of their curative treatment.
The findings of this research will provide valuable insights for healthcare providers to improve patient centered care, optimize treatment outcomes, and enhance supportive care strategies for cervical cancer patients undergoing brachytherapy.
 
Close